Minimum Information About a Bioactive Entity
Names
More detailed information about this field from each metasource.
Minimum Information About a Bioactive Entity
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
MIABE
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Names
More detailed information about this field from each metasource.
Minimum Information About a Bioactive Entity
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
MIABE
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Names
More detailed information about this field from each metasource.
Minimum Information About a Bioactive Entity
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
MIABE
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
MIABE is intended to be used as a guideline which should be consulted prior to the publication of data describing small molecules and their interactions with one or more target molecules. It was developed by representatives of pharmaceutical companies, data resource providers and academic groups.
Description
More detailed information about this field from each metasource.
MIABE is intended to be used as a guideline which should be consulted prior to the publication of data describing small molecules and their interactions with one or more target molecules. It was developed by representatives of pharmaceutical companies, data resource providers and academic groups.
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Webpage:
http://www.psidev.info/miabeWebpage
More detailed information about this field from each metasource.
http://www.psidev.info/miabe
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Publications:
Publications
More detailed information about this field from each metasource.
Minimum information about a bioactive entity (MIABE)
PMID: 21878981
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Publications
More detailed information about this field from each metasource.
Minimum information about a bioactive entity (MIABE)
PMID: 21878981
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
-
Minimum information about a bioactive entity (MIABE)
PubMed citations: 36.
36 articles citing: Minimum information about a bioactive entity (MIABE)
Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments. PMID:34472587
Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments. PMID:33300000
QSAR without borders. PMID:32356548
NutriGenomeDB: a nutrigenomics exploratory and analytical platform. PMID:31665759
Data Mining Approach for Extraction of Useful Information About Biologically Active Compounds from Publications. PMID:31453694
Reliable Target Prediction of Bioactive Molecules Based on Chemical Similarity Without Employing Statistical Methods. PMID:31404334
Challenges of Connecting Chemistry to Pharmacology: Perspectives from Curating the IUPHAR/BPS Guide to PHARMACOLOGY. PMID:30087946
The Alexandria library, a quantum-chemical database of molecular properties for force field development. PMID:29633987
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions. PMID:29276046
VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization. PMID:28978313
Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway. PMID:28910500
Propelling the paradigm shift from reductionism to systems nutrition. PMID:28138347
First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine. PMID:27405781
Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation. PMID:27280890
How should the completeness and quality of curated nanomaterial data be evaluated? PMID:27143028
Cheminformatics Research at the Unilever Centre for Molecular Science Informatics Cambridge. PMID:26435758
Data integration in biological research: an overview. PMID:26336651
Activity, assay and target data curation and quality in the ChEMBL database. PMID:26201396
Curation of chemogenomics data. PMID:26196763
Reporting biological assay screening results for maximum impact. PMID:26194585
Many InChIs and quite some feat. PMID:26081259
QSAR Modeling Using Large-Scale Databases: Case Study for HIV-1 Reverse Transcriptase Inhibitors. PMID:26046311
A brief review of recent Charcot-Marie-Tooth research and priorities. PMID:25901280
Development of data representation standards by the human proteome organization proteomics standards initiative. PMID:25726569
Metadata Standard and Data Exchange Specifications to Describe, Model, and Integrate Complex and Diverse High-Throughput Screening Data from the Library of Integrated Network-based Cellular Signatures (LINCS). PMID:24518066
An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines. PMID:24441647
InChI in the wild: an assessment of InChIKey searching in Google. PMID:23399051
Annotating Human P-Glycoprotein Bioassay Data. PMID:23293680
Taking Open Innovation to the Molecular Level - Strengths and Limitations. PMID:23226167
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. PMID:23197038
Exploitation of genomics in fungicide research: current status and future perspectives. PMID:23157348
Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity'? PMID:22935805
Behavioral barcoding in the cloud: embracing data-intensive digital phenotyping in neuropharmacology. PMID:22652049
Improving integrative searching of systems chemical biology data using semantic annotation. PMID:22401035
Translational informatics: an industry perspective. PMID:22237867
canSAR: an integrated cancer public translational research and drug discovery resource. PMID:22013161
Tags:
Tags
More detailed information about this field from each metasource.
bioactivity
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
biomarker
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
molecular entity
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
molecular interaction
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
small molecule
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
small molecule binding
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
target
metasource: Fairsharing.org
version: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Tags
More detailed information about this field from each metasource.
bioactivity
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
biomarker
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
molecular entity
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
molecular interaction
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
small molecule
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
small molecule binding
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
target
metasource: Fairsharing.orgversion: FAIRsharing.org: MIABE; Minimum Information About a Bioactive Entity; DOI: https://doi.org/10.25504/FAIRsharing.dt7hn8; Last edited: Feb. 12, 2020, 3:23 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
bioactivity biomarker molecular entity molecular interaction small molecule small molecule binding target
Need help integrating and/or managing biomedical data?